BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• Business

  Cadence Pharmaceuticals, Inc. Reports Third Quarter 2010 Financial Results

  November 5, 2010

   · 

  8 min read
• Bio NC

  GlycoMark Receives More than $240,000 to Advance Blood Test for Diabetes and Pre-Diabetes

  November 5, 2010

   · 

  1 min read
• FDA

  Bristol-Myers Squibb Company’s KOMBIGLYZE(TM) XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 Diabetes Mellitus in Adults

  November 5, 2010

   · 

  1 min read
• Biotech Bay

  Gilead Sciences, Inc. to Present at the 2010 Credit Suisse Healthcare Conference on Thursday, November 11

  November 5, 2010

   · 

  1 min read
• Allergies Tied to Higher CHD Risk in Women Under 50

  November 5, 2010

   · 

  1 min read
• Everolimus-eluting Stents Reduce Post-PCI Restenosis and Revascularization Risk

  November 5, 2010

   · 

  1 min read
• Business

  Helix BioMedix, Inc. Reports Third Quarter 2010 Financial Results

  November 5, 2010

   · 

  1 min read
• Bio NC

  TransTech Pharma, Inc. and High Point Pharmaceuticals Awarded $1.96 Million in Grants for Qualifying Therapeutic Development Projects

  November 5, 2010

   · 

  1 min read
• Imposed Dietary Salt Restrictions 20 Times More Effective Than Optional Initiatives

  November 5, 2010

   · 

  1 min read
• Genentech Reports Promising Phase II Results with New Targeted Approach in Advanced Melanoma

  November 5, 2010

   · 

  1 min read